Ultragenyx Pharmaceutical Inc. <RARE.O>: Canaccord Genuity cuts target price to $37 from $83
RARE•Related News
BWX Technologies Inc <BWXT.N>: Jefferies initiates coverage with buy rating; target price $181
BWXT•
Faraday Future signs compliance, localization advisory deal with AIBOT
FFAI•
Snowflake Inc. <SNOW.N>: Scotiabank raises target price to $440 from $320
SNOW•
Smith-Midland CEO Ashley B. Smith acquires 1,275 common shares for $9,804.75
SMID•
ZTO Express files HKEX next-day disclosure, reports share repurchase for cancellation
ZTO•